Cellular Therapy and Cord Blood 2013 Market Report

  • ID: 2393891
  • February 2013
  • 172 Pages
  • Select Biosciences Ltd
1 of 3

This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape. In this comprehensive market report, the authors have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, the report presents primary industry data that the authors have collected as part of their continual industry tracking of this space.

This report analyzes clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and presents the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. The authors also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.

The report provides a detailed quantitative analysis of the cord blood field as it is rapidly evolving. The report's coverage provides hard numbers on sizes of the various registries, the TNC breakouts of banked READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Description of Chapters of this Report

Chapter I. Cellular Therapeutics Market Landscape

- Stem Cell Market Segmentation and Industry Structure
- Quantitative Trends in the Cellular Therapy and Regenerative Medicine Marketplace
- Regenerative Medicine and Stem Cell Research Activity in the US
- Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
- Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
- Breakout of Spending by Product Platforms in Various Spaces
- Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
- Autologous vs. Allogeneic Cellular Therapy: Industry SWOT
- Market Timeline
- Adult Stem Cell Therapy Quantitative Market Forecast
- Stem Cell Research Workflow and Product Development Value Chain
- Quantitative Scale of Cellular Therapy Market Opportunities in Various Disease Classes
- Cellular Therapy Product Pipeline
- Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
- Companies and Marketed Cellular Therapy Products Currently

Chapter II. Cord Blood Market Landscape

- The HSCT Landscape
- HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
- Indications for HSCTs in North America: Disease Classes Addressed, Age of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
- Cost Analyses of HSCTs in the EU vs. US Markets
- Reimbursement Codes and Reimbursed Amounts for Various Procedures Associated with HSCTs
- The Emerging and Evolving Cord Blood Landscape
- Cord Blood Banking Quantitative Market Metrics
- Growth of BM, PBL, and CB Units Worldwide in Public Banks and Registries, Segmented by Country
- Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
- Cord Blood TNCs Landscape and Trends
- Cord Blood Banking Cost Breakouts
- EU and US Cord Blood Transplantation Detailed Cost Breakouts

Chapter III. Stem Cell Opportunities and Funding Sources in Some of the Top Markets Across the European Union

Chapter IV. ATMP Regulatory Routes for Approval of Cellular Therapies in the European Union

Appendix I. Selected Market Opportunities in the Cellular Therapeutics Space

Appendix II. Stem Cell Publications Hotspot Mapping Analysis

Appendix III. Research Methodology

Note: Product cover images may vary from those shown
3 of 3
Question What type of coverage is there with regards to market segmentation in this product(i.e. is it by company or country/region)?
Answer The scope of coverage is by type of stem cell (i.e. adult stem cell classes).
Question Is there information in this product relating to the application of cell therapy and the application's market growth?
Answer Yes, this product provides quantitative market information and forecasts for the growth of cellular therapy mediated by adult stem cells as well as growth of the cord blood field as a means of cellular therapy for hematopoietic malignancies.
Note: Product cover images may vary from those shown





Our Clients

  • Amgen Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Beckman Coulter, Inc.
  • Novartis AG
  • Baxter International Inc.